Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12855648 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
Conditions: Malignant Melanoma;   Pancreatic Cancer;   Colon Cancer;   Cervical Cancer
Intervention: Biological: Survivin peptide vaccine

Study has passed its completion date and status has not been verified in more than two years.